| Cell line name | PFIZi010-C |
|---|---|
| Synonyms | FB65c20 |
| Accession | CVCL_VE71 |
| Resource Identification Initiative | To cite this cell line use: PFIZi010-C (RRID:CVCL_VE71) |
| Comments | From: Pfizer, Inc.; New York; USA. Cell type: Fibroblast; CL=CL_0000057. |
| Disease | Chromosome 16p11.2 deletion syndrome (NCIt: C120408) Proximal 16p11.2 microdeletion syndrome (ORDO: Orphanet_261197) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Originate from same individual | CVCL_VE69 ! PFIZi010-A CVCL_VE70 ! PFIZi010-B |
| Sex of cell | Female |
| Age at sampling | 5-9Y |
| Category | Induced pluripotent stem cell |
| Cross-references | |
| Cell line collections (Providers) | EBiSC; PFIZi010-C
ECACC; 66540172 - Discontinued |
| Cell line databases/resources | hPSCreg; PFIZi010-C |
| Biological sample resources | BioSamples; SAMEA4090955 |
| Encyclopedic resources | Wikidata; Q54947264 |
| Entry history | |
| Entry creation | 14-May-2018 |
| Last entry update | 30-Jan-2024 |
| Version number | 8 |